Topic · page 24 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 921–960 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

Eur J Heart Fail22 Sep 2025
Effect of Glucagon-Like Peptide-1 Receptor Agonists on Heart Failure Outcomes and Cardiovascular Death Across Varying Cardiovascular-Kidney-Metabolic Comorbidity
Meta-analysis
Eur J Heart Fail22 Sep 2025
Deep Phenotyping of Heart Failure with Preserved Ejection Fraction Through Multi-Omics Integration
Diagnostic or prognostic study
Eur J Heart Fail19 Sep 2025
Safety and Prognostic Value of Left Ventricular Endomyocardial Biopsy in Dilated Cardiomyopathy
Cohort study
Eur J Heart Fail16 Sep 2025
Heart Failure Outcomes and Empagliflozin Effects in Patients with Heart Failure and Reduced Ejection Fraction in Sinus Rhythm or Atrial Fibrillation: Data from EMPEROR-Reduced
Secondary analysis
Eur J Heart Fail16 Sep 2025
An Individual Treatment Effect Approach to Predict Response to Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
Secondary analysis
Eur J Heart Fail12 Sep 2025
Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy
Cohort study
JACC Cardiovasc Imaging12 Sep 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy
Cohort study
JACC CardioOncol11 Sep 2025
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis
Diagnostic or prognostic study
Eur J Heart Fail11 Sep 2025
Beta-blockers in Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Chronic Obstructive Pulmonary Disease: Cardiovascular and Respiratory Outcomes
Cohort study
Eur Heart J10 Sep 2025
Fulminant myocarditis: outcome predictors in an international cohort study
Cohort study
Eur J Heart Fail9 Sep 2025
Distinct Blood Volume and Left Ventricular Adaptation to Severe Obesity in Middle-Aged Adults at Risk for Heart Failure
Cross-sectional study
J Am Coll Cardiol9 Sep 2025
Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations
Cohort study
JACC Heart Fail9 Sep 2025
Inferior Vena Cava Ultrasound to Guide Decongestion in Acute Decompensated Heart Failure: A Randomized Controlled Trial
Randomised controlled trial
J Am Coll Cardiol9 Sep 2025
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis
Secondary analysis
J Am Coll Cardiol9 Sep 2025
Racial and Ethnic Differences in Patient Age at First Hospitalization for Heart Failure
Cohort study
JACC Cardiovasc Imaging8 Sep 2025
Atrial Functional Mitral Regurgitation and Exercise-Induced Changes in Heart Failure With Preserved Ejection Fraction
Cohort study
Circulation8 Sep 2025
Adipose Tissue in and Around the Heart: Structural and Functional Insights From Cardiac Magnetic Resonance
Research article
Eur J Heart Fail8 Sep 2025
The CONDUCT-AF Trial: Rationale and Design of a Prospective, Randomized, Multicentre Study Comparing Conduction System and Biventricular Pacing in Patients Undergoing Atrioventricular Node Ablation for Heart Failure with Atrial Fibrillation
Trial design
Eur J Heart Fail8 Sep 2025
Finerenone According to Insulin Resistance in Heart Failure: Insights from the FINEARTS-HF Trial
Secondary analysis
Eur J Heart Fail8 Sep 2025
Ferric Derisomaltose Augments Intrinsic Skeletal Muscle Electron Transport Chain Activity in Heart Failure: A FERRIC-HF II Molecular Substudy
Secondary analysis
Eur Heart J3 Sep 2025
Clinical care of family members of patients with dilated cardiomyopathy
Guideline or statement
Eur J Heart Fail2 Sep 2025
Integrated Trajectories of Systolic and Diastolic Function Differentially Associate with Risk for Heart Failure with Preserved and Reduced Ejection Fraction and Proteomic Profiles
Cohort study
Eur J Heart Fail2 Sep 2025
Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial
Secondary analysis
JAMA Cardiol1 Sep 2025
Sodium-Glucose Cotransporter 2 Inhibitor Use for Heart Failure in US Ambulatory Cardiovascular Care
Cohort study
JACC Heart Fail31 Aug 2025
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy: Primary Results of the ENVAD-HF Trial
Randomised controlled trial
J Am Coll Cardiol31 Aug 2025
Electromechanically Optimized Right Ventricular Pacing for Obstructive Hypertrophic Cardiomyopathy: The EMORI-HCM Trial
Randomised controlled trial
Nat Med31 Aug 2025
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial
Randomised controlled trial
Lancet30 Aug 2025
Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China
Randomised controlled trial
N Engl J Med30 Aug 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Randomised controlled trial
N Engl J Med30 Aug 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Randomised controlled trial
J Am Coll Cardiol30 Aug 2025
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis
Meta-analysis
Lancet30 Aug 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Randomised controlled trial
JACC Cardiovasc Imaging29 Aug 2025
Prognostic Value of Myocardial T1 Mapping and Extracellular Volume Fraction in Heart Failure: A Meta-Analysis
Meta-analysis
Circulation29 Aug 2025
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants
Case-control study
Europace29 Aug 2025
Comprehensive analysis of desmosomal protein remodelling identifies desmocollin-2 as potential biomarker for arrhythmogenic cardiomyopathy
Diagnostic or prognostic study
Europace29 Aug 2025
Implementation of lead V8 as a simple non-invasive tool to improve patient selection in CRT and guide LV lead placement
Cohort study
Europace29 Aug 2025
Association of a mild or an important decline in left ventricular ejection fraction with ventricular tachyarrhythmias, sudden cardiac death and all-cause death in heart failure with preserved ejection fraction: A report from the CHART-2 Study
Cohort study
N Engl J Med29 Aug 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Randomised controlled trial
Eur Heart J29 Aug 2025
Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure
Cohort study
Eur Heart J29 Aug 2025
Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure
Cohort study

All 1,928 Briefs in ExploreShowing Briefs 921–960 of 1,928, newest first